Vitamin E for Period Pain: Why Trial Selection and Dose Details Matter

One vitamin E trial enrolled schoolgirls; a newer trial added vitamin D.¹²

The early positive trial used five treatment days per cycle

The 2005 Tehran study¹ randomized 288 girls and analyzed 278, 139 per group. Its methods specified two 100-IU tablets twice daily, totaling 400 IU daily, for five days around the start of each period over four cycles. Ibuprofen was allowed for persistent pain.¹

At four months, median pain on a 0-to-10 scale was 0.5 with vitamin E versus 6 with placebo. That is a striking reported difference, but it came from one school and adolescents with primary dysmenorrhea. It does not establish treatment for endometriosis, new pain in midlife or every cause of painful periods.¹

The paper’s closing paragraph calls the dose 200 mg daily, unlike the regimen in its methods. That inconsistency is a reason to check the original methods and product formulation rather than copy a summary’s dose.¹

The 2016 review asked a narrower question

The 2016 Cochrane review required moderate to severe primary dysmenorrhea, or specified secondary dysmenorrhea. It excluded mild pain and listed the 2001 and 2005 vitamin E trials among excluded studies, noting that they could include mild dysmenorrhea.³

Its pooled vitamin E-versus-placebo pain analysis used two trials with 135 women. It found no clear difference after one or two cycles. The review also emphasized sparse safety reporting and low or very low certainty across the supplement evidence. Its conclusion should not be presented as a test of every vitamin E trial ever conducted.³

Our ginger and period-supplement evidence guide summarizes that historical review. For vitamin E, the exclusions explain why the review’s result differs from the older positive headline.

A later review reported benefit, with further trials still needed

The 2022 vitamin E meta-analysis included eight articles and 1,002 participants, searching through August 2021. It reported lower pain intensity at one and two months compared with placebo. The authors nevertheless called for larger, higher-quality trials before a firmer conclusion.⁴

That is a more favorable synthesis than the 2016 review, rather than eight newly conducted experiments in 2022. A publication year, number of included studies and eligibility criteria all belong beside a review’s conclusion. The abstract does not establish which regimen best suits an individual patient.⁴

The 2025 combination trial cannot isolate vitamin E

The 2025 study² enrolled 106 women aged 15 to 35, selected for 25-hydroxyvitamin D levels at or below 30 ng/mL. It compared vitamin D plus E with placebo, followed for four months. There was no E-only or D-only treatment group.²

Reported pain scores fell from 7.85 to 3.75 with the combination, versus 7.68 to 6.02 with placebo. These results cannot show how much benefit came from E, D or their combination, or whether the same result applies to people with higher vitamin D levels.²

The authors reported no specific research grant.² An October 2025 correction renumbered figures and captions; it was not a second trial.⁵

Check the label and bleeding risk before supplementing

The NIH Office of Dietary Supplements⁶ gives 15 mg as the daily vitamin E requirement for adults and teens aged 14 to 18. That nutritional requirement is different from a treatment protocol. IU-to-milligram conversion also depends on whether the product contains natural or synthetic alpha-tocopherol.⁶

The same guidance warns that large supplemental doses can increase bleeding risk with anticoagulant or antiplatelet medicines, including warfarin. The amount producing a clinically important interaction is uncertain. Bring all supplements and medicines to a pharmacist or clinician; do not use an old trial’s dosing discrepancy to set your own intake.⁶

Keep a pain record that can guide treatment

“The Supplement Aisle” and “The Pain Kit” in Period, Handled put supplement claims beside established treatment options and a Period Scorecard. Record pain intensity, what you took, the response and which activities pain prevented. Include bleeding changes and pain outside the period.

The NHS⁷ advises assessment when periods become more painful, heavier or irregular, when pain interrupts usual activities, or when there is pain during sex or bleeding between periods. Severe or worse-than-usual pain that has not responded to painkillers needs urgent advice. A supplement trial should not postpone that assessment.⁷